期刊文献+

ZS-1多肽修饰载紫杉醇靶向脂质体抑制NCI-H1299肺癌细胞的研究 被引量:2

Inhibitory effect of ZS-1 modified paclitaxel liposome on lung cancer cell line NCI-H1299 in vitro
下载PDF
导出
摘要 目的以人源性肺癌细胞NCI-H1299为模型,研究ZS-1多肽修饰的载紫杉醇脂质体(ZS-1 modified paclitaxel liposome,ZSLP-PTX)的体外抗肿瘤作用。方法采用薄膜分散法制备ZSLP-PTX,并对其理化性质进行表征。MTT实验研究ZSLP-PTX对NCI-H1299肿瘤细胞的增殖抑制能力,用定性和定量的细胞摄取实验研究ZS-1修饰脂质体与肺癌细胞的亲和力。构建NCI-H1299细胞肿瘤球模型,研究不同脂质体对肿瘤球的穿透能力。结果ZSLP-PTX的粒径为(125.7±18.5)nm,24小时内,在50%的血清中能保持稳定。NCI-H1299细胞和NCI-H1299体外肿瘤球对ZSLP的摄取能力大于LP-PTX(P<0.05);ZSLP-PTX对NCI-H1299细胞的增殖抑制作用显著强于LPPTX(P<0.05)。结论与LP-PTX比较,ZSLP-PTX能够更有效地被NCI-H1299肿瘤细胞所摄取,抑制肿瘤细胞的增殖,具有更强的抗肿瘤作用。 Objective To determine the effect of ZS-1 modified paclitaxel liposome (ZSLP-PTX) on lung cancer cell line NCI-H1299 in vitro. Methods ZSLP-PTX was prepared by film-ultrasonic method. The particle size,Zeta potential and stability in serum were evaluated. The uptake of ZSLP-PTX by NCI-H1299 cells in vitro and the penetration into tumor spheroids were examined. The anti-proliferation effect of ZSLP-PTX was evaluated by MTY assay. Results The average particle diameter of ZSLP-PTX was ( 125.7 ± 18.5 ) nm. The uptake of ZSLP-PTX by NCI-H1299 was significantly higher than that of LP-PTX( P 〈 0.05 ). Strong fluorescence intensity showed a deep penetration of ZSLP-PTX in tumor spheroids. The anti-proliferation effect of ZSLP-PTX was significantly greater than that of LP-PTX ( P 〈 0. 05 ). Conclusion Compared to LP-PTX,ZSLP-PTX can penetrate into NCI-HI299 cells more effectively and exert a stronger antitumor effeet.
出处 《实用肿瘤杂志》 CAS 2014年第2期165-169,共5页 Journal of Practical Oncology
关键词 肺肿瘤 紫杉酚 肽类 脂质体 抗肿瘤药 肿瘤细胞 培养的 lung neoplasms paclitaxel peptides liposomes antineoplastic agents tumor cells, cultured
  • 相关文献

参考文献10

  • 1Sugawara S. Randomized phase n trial of uracilltegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage m non-small-cell lung cancer: NJLCG 0601[J]. Lung Cancer ,2013,81 ( I ) :91 - 96.
  • 2Qin Y. Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery[J]. IntJ Pharmaceutics,2011,419( 1-2) :85 -95.
  • 3LuoJQ. Pharmacokinetic study of ZS-1 , a targeted peptide to NCI-H1299 ,in rats following intravenous administration[J] . Chromatographia , 20 11 ,73 (1-2): 177 - 181.
  • 4Maeda N. Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome[J] .JCR,2004,l00(3) :41 -52.
  • 5Chertok B. Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking[J]. Biomaterials ,2009,30 (35) :6780 - 6787.
  • 6LiJ. Targeting the brain with PEGPLGA nanoparticles modified with phage-displayed peptides[J] . Biomaterials , 2011,32(21) :4943 -4950.
  • 7Zhan C. Cyclic RGD conjugated poly ( ethyleneglycol) -co?poly (lactic acid) micelle enhances paclitaxel anti?glioblas-toma effect[J].J Control Release, 2010, 143 (1) : 136 - 142.
  • 8Shah N. Paclitaxel-loaded PLGA nanparticles surface modified with transferrin and Pluronic _ P85, an in vitro cell line and in vivo biodistribution studies on rat model[J].J Drug Target ,2009 ,17 (7) :533 - 542.
  • 9Gao HL. A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein[J] . Biomaterials , 2011 , 32( 33) :8669 - 8675.
  • 10Torchilin V. Tumor delivery of macromolecular drugs based on the EPR effect[J]. Adv Drug Deliv Rev ,2011 , 63 ( 3 ) , 131 - 135.

同被引文献35

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部